Physician profile
Barrett Johnston
NPI 1962602250
$14,349.77
in general payments reported to CMS, 2019-2025
60 companies · $2,350 in 2025
The $2,350 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,158 · 2020: $1,413 · 2021: $2,471 · 2022: $2,026 · 2023: $2,367 · 2024: $1,565 · 2025: $2,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,056 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,056.33 |
| Travel and Lodging | $225.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,851.21 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Collegium Pharmaceutical, INC. | $1,303.77 | 2019-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $1,054.39 | 2021-2025 | Synchromedii, Kyphon Express II Kyphopak Tray, Inceptiv |
| Relievant Medsystems, INC. | $848.28 | 2021-2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $703.61 | 2019-2025 | Relistor |
| Abbvie INC. | $594.52 | 2021-2025 | |
| Ibsa Pharma INC. | $507.84 | 2020-2025 | Tirosint, Licart, Tirosint |
| Forte Bio-Pharma LLC | $417.19 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Saluda Medical Americas, INC. | $410.74 | 2023-2025 | Evoke, Evoke Scs |
| Teva Pharmaceuticals USA, INC. | $305.44 | 2019-2021 | |
| Amgen INC. | $286.42 | 2019-2022 | |
| Spinal Simplicity, LLC | $284.39 | 2022-2024 | Ha Minuteman G3-R |
| Scilex Pharmaceuticals INC. | $263.92 | 2019-2025 | |
| Biotronik Nro, INC. | $256.21 | 2025 | Prospera |
| Pfizer INC. | $251.00 | 2019-2024 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barrett Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.